Home / Disasters and Accidents / Pilot Drug Test Mystery: Was Cannabis Behind Flight Plunge?
Pilot Drug Test Mystery: Was Cannabis Behind Flight Plunge?
15 Aug
Summary
- An Air India pilot's alleged positive cannabis test followed a flight's sudden altitude loss.
- Investigations are examining multiple factors, not solely the pilot's test results.
- Understanding cannabis impairment timing is complex and crucial for aviation safety.
An Air India pilot allegedly tested positive for cannabis following a flight where the Airbus A320 lost approximately 91 meters of altitude, injuring 17 people. This incident, which occurred on August 4th, is under comprehensive investigation, examining technical, operational, medical, and human factors. While media reports suggest a positive confirmatory test for the captain, Air India has not officially confirmed the result.
Scientific studies indicate that cannabis can impair complex tasks like flying, with residual effects potentially lasting up to 24 hours. However, establishing a precise timeline for impairment after a positive test is challenging due to variable factors such as dosage, consumption method, and individual biology. Unlike alcohol, THC's presence in the body does not always correlate directly with current impairment.
This ambiguity presents a significant challenge for aviation regulators. Canada, for instance, implemented a strict rule prohibiting flight crews from consuming cannabis for at least 28 days before duty. Meanwhile, a US study found THC as a significant factor in pilot drug detections in accident investigations, emphasizing that presence does not equate to impairment.
The Air India investigation must ascertain not only if cannabis was consumed but also if the pilot was impaired during flight and if that impairment contributed to the incident. Air India is expanding its random drug testing for pilots to include all crew members, moving beyond the previous requirement of testing at least 10% of pilots.
